A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

VG290131

The study drug and matching placebo will be administered orally.

Trial Locations (1)

RECRUITING

Linear Clinical Research Ltd, Nedlands

All Listed Sponsors

collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Zhejiang Vimgreen Pharmaceuticals, Ltd.

INDUSTRY